SPECCHIA, Giorgina
 Distribuzione geografica
Continente #
NA - Nord America 22.744
AS - Asia 7.566
EU - Europa 7.187
SA - Sud America 2.088
AF - Africa 333
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 39.937
Nazione #
US - Stati Uniti d'America 22.478
SG - Singapore 3.237
DE - Germania 2.010
CN - Cina 1.973
BR - Brasile 1.799
RU - Federazione Russa 1.196
HK - Hong Kong 1.144
SE - Svezia 1.097
IT - Italia 795
GB - Regno Unito 594
VN - Vietnam 453
FI - Finlandia 442
UA - Ucraina 424
FR - Francia 192
IN - India 180
CI - Costa d'Avorio 167
CA - Canada 133
AR - Argentina 116
ID - Indonesia 91
MX - Messico 85
BD - Bangladesh 84
BE - Belgio 72
PL - Polonia 72
IE - Irlanda 67
ZA - Sudafrica 66
TR - Turchia 54
IQ - Iraq 52
JP - Giappone 50
NL - Olanda 41
EC - Ecuador 35
ES - Italia 34
VE - Venezuela 32
UZ - Uzbekistan 30
AT - Austria 28
CZ - Repubblica Ceca 28
MA - Marocco 25
SA - Arabia Saudita 25
CO - Colombia 24
PY - Paraguay 24
LT - Lituania 23
KR - Corea 22
CL - Cile 18
JO - Giordania 18
IR - Iran 16
PK - Pakistan 16
UY - Uruguay 16
NP - Nepal 14
OM - Oman 14
PE - Perù 14
RO - Romania 14
TN - Tunisia 14
KE - Kenya 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
JM - Giamaica 11
KZ - Kazakistan 11
ET - Etiopia 10
AU - Australia 9
DZ - Algeria 9
EG - Egitto 9
TH - Thailandia 8
AZ - Azerbaigian 7
BY - Bielorussia 7
CH - Svizzera 7
BO - Bolivia 6
EU - Europa 6
HN - Honduras 6
PA - Panama 6
TW - Taiwan 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
RS - Serbia 5
SN - Senegal 5
BB - Barbados 4
BH - Bahrain 4
EE - Estonia 4
GT - Guatemala 4
HU - Ungheria 4
LB - Libano 4
MY - Malesia 4
PH - Filippine 4
TT - Trinidad e Tobago 4
BN - Brunei Darussalam 3
DK - Danimarca 3
GE - Georgia 3
LV - Lettonia 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
GF - Guiana Francese 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
ML - Mali 2
MT - Malta 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
SC - Seychelles 2
Totale 39.901
Città #
Fairfield 3.138
Ashburn 2.246
Woodbridge 2.046
Singapore 1.630
Chandler 1.570
Houston 1.564
Seattle 1.331
Hong Kong 1.138
Cambridge 1.130
Wilmington 1.030
Ann Arbor 987
Jacksonville 982
Nyköping 853
Beijing 598
New York 483
Lawrence 375
Roxbury 375
Los Angeles 331
Nanjing 290
Bari 259
Des Moines 250
Dallas 246
Boardman 218
Munich 171
Abidjan 166
Princeton 164
San Diego 154
Ho Chi Minh City 150
Brooklyn 148
São Paulo 147
Inglewood 135
Helsinki 103
Buffalo 99
Santa Clara 95
Moscow 94
Shenyang 92
Hebei 89
Nanchang 89
Hanoi 85
London 82
Dearborn 80
Brussels 71
Jiaxing 66
Dublin 62
Tianjin 62
Jakarta 61
Redwood City 61
Changsha 59
Chicago 59
Rio de Janeiro 57
Falkenstein 56
Pune 54
Warsaw 53
Denver 46
Paris 44
Frankfurt am Main 43
Johannesburg 43
Turku 43
Chennai 42
Council Bluffs 42
Montreal 42
Belo Horizonte 39
Guangzhou 39
Atlanta 38
Dong Ket 37
Tokyo 37
The Dalles 36
Rome 35
Columbus 34
Nuremberg 33
Brasília 32
San Francisco 32
Curitiba 31
Marseille 31
Shanghai 31
Toronto 31
Tashkent 29
Mexico City 27
Milan 27
Jinan 26
Porto Alegre 26
Stockholm 26
Boston 25
Phoenix 25
Norwalk 23
Ankara 22
Baghdad 22
Campinas 22
Salvador 22
Dhaka 21
Hefei 20
Poplar 20
Falls Church 19
Amsterdam 18
Haiphong 18
Brno 17
Guarulhos 17
Manchester 17
Charlotte 16
Mumbai 16
Totale 27.316
Nome #
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 224
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 221
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 206
Monosomal karyotype in myeloid neoplasias: a literature review 197
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 195
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 190
Isolation and characterization of neural stem cells from dystrophic mdx mouse 189
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 186
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 185
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 181
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 179
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 177
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 175
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 175
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 173
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 172
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 171
A fractal analysis of the spatial distribution of tumoral mast cells in lymph nodes and bone marrow 171
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 169
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 167
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 166
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 165
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 165
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 163
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 163
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 163
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 159
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 159
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 155
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 154
Decreased TET2 gene expression during chronic myeloid leukemia progression 153
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 152
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 151
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 150
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 149
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 149
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 148
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 147
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 147
A role of light as potential biomarker for progression of smoldering to symptomatic multiple myeloma 145
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 144
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 144
Non-treatment-related chronic myeloid leukemia as a second malignancy 143
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 143
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 143
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 142
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 142
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 141
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 139
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 139
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 138
Typhlitis complicating induction therapy in adult acute myeloid leukemia 138
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 138
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 137
Vascular Endothelial Growth Factor Serum Levels Are Elevated in Patients with Hereditary Hemorrhagic Telangiectasia 137
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 136
Cardiovascular events and intensity of treatment in polycythemia vera. 134
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 134
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients 134
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 133
CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP) 133
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 132
CT-guided needle biopsy performed with modified coaxial technique in the diagnosis of malignant lymphomas 131
A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative 131
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 130
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 130
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 130
Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: a case report and review of the literature 128
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 128
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 128
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 127
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 127
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 125
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 125
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 125
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 124
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 124
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 123
Concomitant tetrasomy 3q and trisomy 18 in CD5- CD13+ chronic lymphocytic leukemia 123
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 123
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto 123
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 123
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 123
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 123
null 122
Autoimmune Myelofibrosis: report of three cases and review of the literature 121
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 120
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 120
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 120
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 119
ANALYSIS OF PROGNOSTIC FACTORS AND TIME TO FIRST TREATMENT IN YOUNG PATIENTS (<55 YEARS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE CENTER EXPERIENCE 118
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 118
Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics. 116
Extramedullary disease in acute promyelocytic leukemia: two-in-one disease. 116
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis 116
null 115
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 115
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience 115
MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9) 114
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study) 114
Totale 14.503
Categoria #
all - tutte 166.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.365 0 0 0 0 0 328 310 423 294 504 268 238
2021/20222.686 205 263 26 89 126 258 129 123 207 218 449 593
2022/20234.152 611 496 252 349 480 587 42 462 684 31 76 82
2023/20241.760 160 277 73 88 181 596 32 49 9 62 28 205
2024/20256.614 192 123 538 273 178 576 616 597 299 392 940 1.890
2025/20267.338 1.987 660 987 1.798 1.669 237 0 0 0 0 0 0
Totale 40.830